Adynovate 500 Unit (Antihemophilic Factor (Recombinant), Pegylated KIT) 500 UNIT

ADYNOVATE 500 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This intravenous kit helps manage bleeding episodes and prevent complications.

Strength

500 UNIT

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADYNOVATE 500 Unit is primarily used to control and prevent bleeding in patients with hemophilia B, a condition where blood does not clot properly. It is designed to replace the missing clotting factor, helping to manage bleeding episodes and support surgical interventions. This medication is tailored for intravenous administration, providing targeted support for those with this specific clotting disorder.

Side Effects

Common effects of ADYNOVATE 500 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild flu-like symptoms or headaches. These effects are generally temporary and should be monitored. If severe or persistent, consult a healthcare provider.

Precautions & Warnings

ADYNOVATE 500 Unit should be handled with care, ensuring proper storage and administration techniques. It is essential to follow medical guidance for use, especially regarding dosage and frequency. Patients with known allergies to any components should avoid this medication. Always inform healthcare providers about existing conditions or medications before use.

Avoid Interactions

ADYNOVATE 500 Unit may interact with certain medications, particularly those affecting blood clotting. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect blood clotting should be used with caution. Always consult a healthcare professional for personalized advice.

Frequently Asked Questions

ADYNOVATE 500 Unit is used to manage and prevent bleeding episodes in patients with hemophilia B.

ADYNOVATE 500 Unit is administered intravenously, typically under medical supervision.

Common side effects may include localized reactions at the injection site, such as redness or swelling, and mild flu-like symptoms.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety.

ADYNOVATE 500 Unit should be stored as per the manufacturer's instructions to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.